It just fell on the news: Pfizer’s anti-Covid pill has been approved by health authorities in Canada according to the media 20 Minutes. Ended doliprane, the Ministry of Health is betting on a brand new drug and announced on Monday the authorization of the anti-Covid viral treatment developed by Pfizer, marketed under the name Paxlovid, according to a press release.
This drug would be suitable for “adults with a mild or moderate form of Covid-19 at high risk of progression to serious illness, including a risk of hospitalization or death”, it is specified. “No medicine, not even Paxlovid, can replace vaccination” warns the ministry. Health authorities claim that this treatment is “significant new therapeutic option”. People infected with Covid-19 will be able to treat themselves at home thanks to this treatment. The approval comes at the right time, because like many countries, Canada is facing an increase in contamination due to the Omicron variant, which is very easily transmitted. On January 12, the country was recording an average of more than 37,500 new cases per day. A figure “underestimated” according to the health authorities.
“Today’s announcement is particularly important because access to easy-to-use treatments could help reduce the severity of Covid-19 in newly infected adults and those at high risk of developing severe disease.”, said Theresa Tam, the chief public health officer of Canada, in front of the media. Canada had already made an announcement last December. The country had reached an agreement with the American giant with the aim of receiving nearly a million doses of this oral antiviral treatment, details the media. Le Figaro. So will this drug also be marketed in France? We don’t know at the moment…
See also: Big argument between Cauet and Patrick Bruel in a parking lot around vaccination: the host throws everything on the radio!
Writing